Parag V. Meswani

Corporate Officer/Principal at ACADIA PHARMACEUTICALS INC.

Health Technology

Consumer Services

Profile

Parag V.
Meswani is currently the Senior Vice President-Trofinetide at ACADIA Pharmaceuticals, Inc. Prior to this, he held positions at Biogen, Inc. as the Chief Executive Officer-Commercial Operations, at Spark Therapeutics, Inc. as the Head-US Marketing, and at Sio Gene Therapies, Inc. as the Chief Commercial Officer.
Dr. Meswani has an MBA from The Trustees of Columbia University in The City of New York, an undergraduate and doctorate degree from Ernest Mario School of Pharmacy, and another MBA from Columbia Business School.

Parag V. Meswani active positions

Companies	Position	Start
ACADIA PHARMACEUTICALS INC.	Corporate Officer/Principal	01/04/2022

All active positions of Parag V. Meswani

Former positions of Parag V. Meswani

Companies	Position	End
SIO GENE THERAPIES INC.	Chief Operating Officer	06/10/2020
BIOGEN INC.	Corporate Officer/Principal	-
SPARK THERAPEUTICS, INC.	Sales & Marketing	-

See the detail of Parag V. Meswani's experience

Training of Parag V. Meswani

Ernest Mario School of Pharmacy	Doctorate Degree
Columbia Business School	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Parag V. Meswani's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BIOGEN INC.	Health Technology
ACADIA PHARMACEUTICALS INC.	Health Technology

Private companies	2
Sio Gene Therapies, Inc. Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY.	Health Technology
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.	Health Technology

Private companies